User profiles for Hong Zhu
Hyper-parameter optimization: A review of algorithms and applications
T Yu, H Zhu - arXiv preprint arXiv:2003.05689, 2020 - arxiv.org
Since deep neural networks were developed, they have made huge contributions to everyday
lives. Machine learning provides more rational advice than humans are capable of in …
lives. Machine learning provides more rational advice than humans are capable of in …
[HTML][HTML] Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
H Su, M Yang, C Wan, LX Yi, F Tang, HY Zhu, F Yi… - Kidney international, 2020 - Elsevier
Although the respiratory and immune systems are the major targets of Coronavirus Disease
2019 (COVID-19), acute kidney injury and proteinuria have also been observed. Currently, …
2019 (COVID-19), acute kidney injury and proteinuria have also been observed. Currently, …
Game consumption and the 2019 novel coronavirus
…, X Xie, X Cai, J Huang, X Tian, H Zhu - The Lancet Infectious …, 2020 - thelancet.com
In December, 2019, the 2019 novel coronavirus (2019 nCoV) infecting humans was first
identified in Wuhan, China. 1–3 As of Feb 3, 2020, the National Health Commission of China …
identified in Wuhan, China. 1–3 As of Feb 3, 2020, the National Health Commission of China …
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
We report here that BID, a BH3 domain–containing proapoptotic Bcl2 family member, is a
specific proximal substrate of Casp8 in the Fas apoptotic signaling pathway. While full-length …
specific proximal substrate of Casp8 in the Fas apoptotic signaling pathway. While full-length …
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Apoptosis, or cellular suicide, is important for normal development and tissue homeostasis,
but too much or too little apoptosis can also cause disease 1 , 2 . The family of cysteine …
but too much or too little apoptosis can also cause disease 1 , 2 . The family of cysteine …
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
E Selvin, MW Steffes, H Zhu, K Matsushita… - … England Journal of …, 2010 - Mass Medical Soc
Background Fasting glucose is the standard measure used to diagnose diabetes in the United
States. Recently, glycated hemoglobin was also recommended for this purpose. Methods …
States. Recently, glycated hemoglobin was also recommended for this purpose. Methods …
Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
The mammalian interleukin-lfl-converting enzyme (ICE) has sequence similarity to the C.
elegans cell death gene ted-3. We show here that overexpression of the murine ICE (mlCE) …
elegans cell death gene ted-3. We show here that overexpression of the murine ICE (mlCE) …
Software unit test coverage and adequacy
Objective measurement of test quality is one of the key issues in software testing. It has been
a major research focus for the last two decades. Many test criteria have been proposed and …
a major research focus for the last two decades. Many test criteria have been proposed and …
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
…, E Hogg, D Welch, L Manness, C Lin, J Yu, H Zhu… - Nature medicine, 2003 - nature.com
Amyloid-β peptide (Aβ) interacts with the vasculature to influence Aβ levels in the brain and
cerebral blood flow, providing a means of amplifying the Aβ-induced cellular stress …
cerebral blood flow, providing a means of amplifying the Aβ-induced cellular stress …
MRD-directed risk stratification treatment may improve outcomes of t (8; 21) AML in the first complete remission: results from the AML05 multicenter trial
HH Zhu, XH Zhang, YZ Qin, DH Liu… - Blood, The Journal …, 2013 - ashpublications.org
We aimed to improve the outcome of t(8;21) acute myeloid leukemia (AML) in the first complete
remission (CR1) by applying risk-directed therapy based on minimal residual disease (…
remission (CR1) by applying risk-directed therapy based on minimal residual disease (…